Francesco Ingenito
Naples, 80131, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Ex.50.T aptamer impairs tumor-stroma cross-talk in breast cancer by targeting gremlin-1.
Journal: Cell death discovery
Published: May 21, 2024
MCT4-driven CAF-mediated metabolic reprogramming in breast cancer microenvironment is a vulnerability targetable by miR-425-5p.
Journal: Cell death discovery
Published: June 29, 2023
Erratum: Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancer.
Journal: Molecular therapy. Nucleic acids
Published: September 12, 2022
Comparative Proteomic Profiling of Secreted Extracellular Vesicles from Breast Fibroadenoma and Malignant Lesions: A Pilot Study.
Journal: International journal of molecular sciences
Published: February 04, 2022
Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancer.
Journal: Molecular therapy. Nucleic acids
Published: October 22, 2021
Modulating the Crosstalk between the Tumor and the Microenvironment Using SiRNA: A Flexible Strategy for Breast Cancer Treatment.
Journal: Cancers
Published: October 30, 2020
Identification of a novel RNA aptamer that selectively targets breast cancer exosomes.
Journal: Molecular therapy. Nucleic acids
Published: July 27, 2020
miR-34c-3p targets CDK1 a synthetic lethality partner of KRAS in non-small cell lung cancer.
Journal: Cancer gene therapy
Published: March 18, 2020
miR-216a Acts as a Negative Regulator of Breast Cancer by Modulating Stemness Properties and Tumor Microenvironment.
Journal: International journal of molecular sciences
Published: February 03, 2020
The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications.
Journal: International journal of molecular sciences
Published: August 09, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026